JWH-250 is a synthetic cannabinoid receptor agonist that has been detected in products since the late 2000s. It was created by Dr. John W. Huffman and a report on it was released in 2005 by Huffman et al.
The drug is a phenylacetylindole and it works as an agonist at CB1 and CB2 receptors. It has an affinity of ~11 nM at CB1 and ~33 nM at CB2.
A few years after it was first mentioned in the literature, JWH-250 appeared on the market, with the first detection coming from German police in May 2009. They found the drug in an herbal smoking mixture.
It’s also been detected in powders and blends sold via the internet to researchers in Japan. Those samples contained 77-165 mg per product.
Because of the way it’s been sold, it’s likely people have encountered JWH-250 without realizing it.
JWH-250 = 1-pentyl-3-(2-methoxyphenylacetyl)indole
Dose
Not currently available due to a lack of information.
Timeline
Not currently available due to a lack of information.
Experience Reports
References
(2005) 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles